Company profile: Academia.edu
1.1 - Company Overview
Company description
- Provider of the largest and fastest-growing platform for sharing academic research, enabling academics to share research papers and aiming to accelerate and democratize academic research. Over 150 million academics have signed up, adding 25 million papers, with more than 100,000 people joining each day.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Academia.edu
Indigo BioAutomation
HQ: United States
Website
- Description: Provider of automated data analysis, management, and integration solutions for clinical and life science laboratories, including ASCENT for LC-MS/MS workflows and ARQ for PCR data. Offers vendor-neutral SaaS platforms with machine learning/AI, a quality rule system applying lab SOPs across instruments, and hosted access from anywhere for flexible, efficient operations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Indigo BioAutomation company profile →
uMotif
HQ: United Kingdom
Website
- Description: Provider of a scalable, engaging, patient-centred data capture platform for modern clinical research, enabling compliant, validated e-consent, eCOA, ePRO, PROM and PREM. Delivers configurable patient engagement, study-specific eDiaries on mobile and web, complex ClinROs with audio upload, telehealth for onboarding and consent, and integration with devices, sensors and third-party systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full uMotif company profile →
Genuity Science
HQ: United States
Website
- Description: Provider of clinco-omics data analysis solutions and genomic sequence data for researchers, with a platform for study design, sequencing, storage, interpretation, secondary analysis, and scalable analytics. Offers disease-specific clinical omics datasets (CNS, cardiometabolic, inflammatory), powered datasets, deeply phenotyped whole genomes, longitudinal data, and population-scale expertise applying deep learning to improve patient health using the human genome.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genuity Science company profile →
Neuron23
HQ: United States
Website
- Description: Provider of drug development programs for neurological and inflammatory diseases, including Parkinson's and Alzheimer's. Pipeline includes NEU-723, a brain-penetrant LRRK2 inhibitor in Phase 1 for Parkinson's; NEU-411, a follow-on LRRK2 inhibitor for Parkinson's expected to enter clinical trials in 2023; and TYK2 programs targeting systemic inflammation, neuroinflammation and MS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neuron23 company profile →
Nomic Bio
HQ: Canada
Website
- Description: Provider of a proteomic technology platform leveraging DNA nanotechnology to understand, detect, and treat diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nomic Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Academia.edu
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Academia.edu
2.2 - Growth funds investing in similar companies to Academia.edu
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Academia.edu
4.2 - Public trading comparable groups for Academia.edu
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →